REPORT ID 6863

Global Candidiasis Therapeutics Market Research Report 2017

Publish Date
1-Nov-17
Pages
113
Format
Electronic (PDF)

In this report, the global Candidiasis Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Candidiasis Therapeutics in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Candidiasis Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Novartis AG
    Amgen
    F. Hoffmann-La Roche Ltd.
    Bayer-Algeta
    Merrion Pharmaceuticals Plc.
    Ablynx
    Genta Incorporated
    Galapagos NV
    Catena Pharmaceuticals Inc.
    Digna Biotech S.L.
    Medivir AB
    Amura Holdings
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Doxorubicin
    Cisplatin
    7Carboplatin
    Etoposide
    Ifosfamide
    Cyclophosphamide
    Methotrexate
    Vincristine
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Multispecialty Hospitals
    Cancer Research Institutes
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Candidiasis Therapeutics Market Research Report 2017
1 Candidiasis Therapeutics Market Overview
    1.1 Product Overview and Scope of Candidiasis Therapeutics
    1.2 Candidiasis Therapeutics Segment by Type (Product Category)
        1.2.1 Global Candidiasis Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Candidiasis Therapeutics Production Market Share by Type (Product Category) in 2016
        1.2.3 Doxorubicin
        1.2.4 Cisplatin
        1.2.5 7Carboplatin
        1.2.6 Etoposide
        1.2.7 Ifosfamide
        1.2.8 Cyclophosphamide
        1.2.9 Methotrexate
        1.2.10 Vincristine
    1.3 Global Candidiasis Therapeutics Segment by Application
        1.3.1 Candidiasis Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Multispecialty Hospitals
        1.3.3 Cancer Research Institutes
        1.3.4 Others
    1.4 Global Candidiasis Therapeutics Market by Region (2012-2022)
        1.4.1 Global Candidiasis Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Candidiasis Therapeutics (2012-2022)
        1.5.1 Global Candidiasis Therapeutics Revenue Status and Outlook (2012-2022)
        1.5.2 Global Candidiasis Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Candidiasis Therapeutics Market Competition by Manufacturers
    2.1 Global Candidiasis Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Candidiasis Therapeutics Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Candidiasis Therapeutics Production and Share by Manufacturers (2012-2017)
    2.2 Global Candidiasis Therapeutics Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Candidiasis Therapeutics Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Candidiasis Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Candidiasis Therapeutics Market Competitive Situation and Trends
        2.5.1 Candidiasis Therapeutics Market Concentration Rate
        2.5.2 Candidiasis Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Candidiasis Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Candidiasis Therapeutics Capacity and Market Share by Region (2012-2017)
    3.2 Global Candidiasis Therapeutics Production and Market Share by Region (2012-2017)
    3.3 Global Candidiasis Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Candidiasis Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Candidiasis Therapeutics Consumption by Region (2012-2017)
    4.2 North America Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.4 China Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.7 India Candidiasis Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Candidiasis Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global Candidiasis Therapeutics Production and Market Share by Type (2012-2017)
    5.2 Global Candidiasis Therapeutics Revenue and Market Share by Type (2012-2017)
    5.3 Global Candidiasis Therapeutics Price by Type (2012-2017)
    5.4 Global Candidiasis Therapeutics Production Growth by Type (2012-2017)

6 Global Candidiasis Therapeutics Market Analysis by Application
    6.1 Global Candidiasis Therapeutics Consumption and Market Share by Application (2012-2017)
    6.2 Global Candidiasis Therapeutics Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Candidiasis Therapeutics Manufacturers Profiles/Analysis
    7.1 Novartis AG
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Novartis AG Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Amgen
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Amgen Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 F. Hoffmann-La Roche Ltd.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Bayer-Algeta
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Bayer-Algeta Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Merrion Pharmaceuticals Plc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Ablynx
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Ablynx Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Genta Incorporated
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Genta Incorporated Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Galapagos NV
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Galapagos NV Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Catena Pharmaceuticals Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Digna Biotech S.L.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Candidiasis Therapeutics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Digna Biotech S.L. Candidiasis Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Medivir AB
    7.12 Amura Holdings

8 Candidiasis Therapeutics Manufacturing Cost Analysis
    8.1 Candidiasis Therapeutics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Candidiasis Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Candidiasis Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Candidiasis Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Candidiasis Therapeutics Market Forecast (2017-2022)
    12.1 Global Candidiasis Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Candidiasis Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Candidiasis Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Candidiasis Therapeutics Price and Trend Forecast (2017-2022)
    12.2 Global Candidiasis Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Candidiasis Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Candidiasis Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Candidiasis Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer